Conflicts of Interest
Ricardo Fernandes received honoraria from Canadian Agency for Drugs and Technologies in Health (CADTH), Bayer, Pfizer, Ipsen, BMS, Merck, Novartis, and Janssen. Gregory Pond received consulting fees from Merck, Profound Medical and Astra-Zeneca, received honoraria for participation on an advisory board for Takeda, and has a close family member who is an employee of Roche Canada, and who owns stock in Roche Ltd. David Cella is the President of FACIT.org. The other authors declare no competing interests.